Pfizer’s Vyndaqel recommended by NICE to treat rare heart disease ATTR-CM
Approximately 1,500 people in England are affected by transthyretin amyloidosis cardiomyopathy
Approximately 1,500 people in England are affected by transthyretin amyloidosis cardiomyopathy
The mosquito-borne viral disease often causes sudden, large outbreaks with high attack rates
The deal gives Sanofi a licence to use Novavax’s COVID-19 vaccine in combination with its own flu vaccines
Approximately 1,500 people in England are affected by transthyretin amyloidosis cardiomyopathy
Both awards are open for entry until 17 May 2024 and the live awards ceremony will take place on 11 July 2024
Healthcare agencies can submit their entries free of charge with a deadline of 30 April
May 8, 2024 | Appointments
Wickersham recently led Gilead’s liver disease and COVID-19 business unit in the US
Read MoreApr 23, 2024 | Thought Leadership
By Jake Crute
Read MoreApr 22, 2024 | Thought Leadership
By Phil Streit
Read MoreApr 17, 2024 | Appointments
Dunford recently served as executive creative director at TBWA\WorldHealth
Read MoreMay 7, 2024 | Intelligence
Why understanding all aspects of the patient journey is imperative to successful clinical research
Read MoreMay 2, 2024 | Intelligence
Looking at some of the chief opportunities and challenges for digital health providers in implementing and scaling technological solutions in the UK
Read MoreApr 30, 2024 | Intelligence
Research has long shown a strong connection between disease and the gut microbiome
Read MoreApr 25, 2024 | Intelligence
With 14 million people in Europe expected to suffer from Alzheimer’s and other forms of dementia by 2030, the race is on to find a treatment to not only slow its course, but even prevent the development of the disease
Read MoreApr 24, 2024 | Intelligence
PME speaks to Lorna Pender, Global Patient Engagement Lead at Clinigen, about the treatment options available to patients with rare diseases and the barriers that are hindering access
Read MoreApr 19, 2024 | Intelligence
Industry is urged to ditch the simple slogans and instead embrace the complexity, as delving more deeply could improve success rates
Read MoreMay 7, 2024 | Mtech Access|GP contract, Market Access, NHS, NHS Whispers, Operational Planning Guidance, primary care
What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract …
May 3, 2024 | Innovative Trials|Patient Retention, clinical trials, patient engagement, patient recruitment, pharmaceutical industry
Join this live webinar focusing on patient recruitment and retention in rare disease trials.
May 2, 2024 | Medscape Education Global|
It’s time for the CME industry to evolve. During recent years, access to data, modern technologies, and methodologies have allowed for deeper analysis of data …
May 1, 2024 | Springer Nature|Cancer therapy, biopharma dealmakers, biopharma investment, biopharma partner, dealmaking, radiopharmaceuticals
The future looks hopeful as second-generation radiopharmaceuticals venture into uncharted territories.
May 1, 2024 | Springer Nature|Healthcare Advertising, clinicial advertising, health awareness days, medical marketing, physician marketing
Are you marketing to clinical audiences around upcoming health awareness days?
May 7, 2024 | Mednet Group|AI, Innovation, Project Management, artificial intelligence, thought leadership
Explore the ways we’re adapting to work with AI, not against it
May 2, 2024 | Impetus Digital|Access, clinical trials, digital health, digital tools, oncology, patient insight-gathering, reimbursement
With rapid growth comes growing pains…
April 30, 2024 | Mtech Access|AMCP, Health Economics, ICER, US healthcare, USA, health economic evaluation
Hannah Palin (Director – Market Access) and Calum Jones (Associate Director – Health Economics) explore the landscape for economic evaluation in the US. They highlight …
April 24, 2024 | Research Partnership|Syndicated, market research, oncology, therapy watch
This Acute Myeloid Leukemia infographic offers a snapshot of the real-world patient insights collected by our Therapy Watch study, based on data collected from a …
April 22, 2024 | Research Partnership|
Authored by: Ellie Forde and Mark Braund, Directors
May 9, 2024 | Impetus Digital | DOL, HCP advisor, HCP engagement, Healthcare Events, Healthcare Meetings, Impetus Digital, KOL, Pharma meetings, Pharma tips, Pharma trends, Pharme events, Virtual advisory boards, advisor engagement, virtual meetings
Account Specialist - Respiratory - Kent & Medway
Account Manager - Oxford office/Hybrid/Remote working
Key Account Manager - Cardiology - Humber Coast & Vale
Senior Medical Science Liaison - North of England/Scotland/NI